CHURG-STRAUSS SYNDROME
Clinical trials for CHURG-STRAUSS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CHURG-STRAUSS SYNDROME trials appear
Sign up with your email to follow new studies for CHURG-STRAUSS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare disease: can NS-229 help patients cut steroids?
Disease control Recruiting nowThis study tests a new drug, NS-229, for people with a rare disease called eosinophilic granulomatosis with polyangiitis (EGPA), which causes inflammation in blood vessels. The goal is to see if NS-229 can help patients achieve remission (no symptoms) while taking a lower dose of…
Matched conditions: CHURG-STRAUSS SYNDROME
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
Scientists hunt for clues to tame rare immune disease
Knowledge-focused Recruiting nowThis study follows 700 people with eosinophilic granulomatosis with polyangiitis (EGPA), a rare immune disorder causing asthma, high eosinophil levels, and blood vessel inflammation. Researchers aim to discover biological markers that can measure how active the disease is and how…
Matched conditions: CHURG-STRAUSS SYNDROME
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 26, 2026 08:40 UTC
-
Scientists hunt for vasculitis clues in tissue samples
Knowledge-focused Recruiting nowThis study collects existing tissue samples from 1,000 people with various forms of vasculitis, a group of rare blood vessel diseases. Researchers will analyze the samples along with health data to find genes and other factors that cause these conditions. The goal is to spark new…
Matched conditions: CHURG-STRAUSS SYNDROME
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC